SSTR2 and meningioma: Interestingly, we could not detect a significant increase in 53BP1 foci numbers compared to controls at both day 0 and day 2 post-therapy for one meningioma sample (MO-12), for which tumor tissue stained only weakly for SSTR2 (Figure 4D–F).